跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
吳 明順
副教授
,
消化內科
合聘副教授
,
國際醫學研究碩士學位學程
合聘副教授
,
國際醫學研究博士學位學程
合聘副教授
,
醫學教育暨人文學科
主治醫師
,
臺北市立萬芳醫院
成員
,
臺北醫學大學細胞治療與再生醫學研究中心
成員
,
臺北醫學大學消化醫學研究中心
https://orcid.org/0000-0002-5755-9062
電子郵件
mswu
tmu.edu
tw
h-index
1757
引文
22
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1991 …
2026
每年研究成果
概覽
指紋
網路
專案
(13)
研究成果
(72)
資料集
(5)
類似的個人檔案
(6)
指紋
查看啟用 Ming-Shun Wu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Colon Carcinoma
100%
Phosphotransferase
81%
Liver Cell Carcinoma
67%
Colorectal Carcinoma
53%
Nitric Oxide
51%
Evodiamine
51%
Lipopolysaccharide
51%
Lipoteichoic Acid
51%
Reactive Oxygen Metabolite
46%
N-Acetylcysteine
43%
Heme Oxygenase 1
42%
Antioxidant
40%
Cytotoxicity
39%
Lipid
38%
Protein Kinase B
36%
Ovary Cancer
34%
Fisetin
34%
Bacteriophage
34%
Protein P53
32%
Protoporphyrin Cobalt
31%
Phosphotransferase Inhibitor
25%
Sorafenib
24%
Caspase 3
23%
Inflammation
23%
Hepatitis B Virus
22%
Protein Kinases
22%
Anti-Inflammatory Drug
22%
Rat
21%
anthra[1,9 Cd]pyrazol 6(2h) One
21%
Acetic Acid Derivative
21%
Tetradium ruticarpum
21%
Cysteine
21%
Infection
20%
Nuclear Factor
19%
Alternative Complement Pathway C3 C5 Convertase
19%
Chronic Hepatitis B
19%
Nocodazole
18%
Paclitaxel
18%
Nonalcoholic Fatty Liver
17%
Hydrogen Peroxide
17%
Antioxidant Capacity
17%
Liver Cancer
17%
Liver Disease
17%
Normal Human
17%
Anaplastic Thyroid Carcinoma
17%
Scutellaria baicalensis
17%
Mammalian Target of Rapamycin
17%
Nilotinib
17%
Trilinolein
17%
Ticlopidine
17%
Medicine and Dentistry
Hepatocellular Carcinoma
93%
Lenvatinib
51%
Acute Pancreatitis
34%
Tumor Ablation
34%
Colorectal Carcinoma
34%
Liver Cancer
34%
Overall Survival
32%
Progression Free Survival
31%
Albumin
27%
Bilirubin
27%
Diseases
26%
Neoplasm
24%
Systematic Review
21%
Liver Disease
20%
Oral
20%
Prevalence
19%
Microbiome
19%
Ablation Therapy
19%
Inflammatory Cytokine
18%
Meta-Analysis
17%
Percutaneous Endoscopic Gastrostomy
17%
Esophagectomy
17%
Granulomatous Hepatitis
17%
Transforming Growth Factor Beta1
17%
Seroepidemiology
17%
Tubular Adenoma
17%
Pronase
17%
Campylobacter Coli
17%
Premedication
17%
Gastroesophageal Reflux
17%
Gut
17%
Anti-Inflammatory Drug
17%
Telehealth
17%
Ulcer
17%
Sarcopenia
17%
Smooth Muscle Actin
17%
Vein Occlusion
17%
Liver Tumor
17%
Sorafenib
17%
Spontaneous Bacterial Peritonitis
17%
Signet Ring Cell Carcinoma
17%
Ampulla of Vater
17%
Hydrocele
17%
Clinical Stage
17%
Medical Specialty
17%
Chronic Hepatitis B
17%
N-Acetylcysteine
17%
Bacterial Infection
17%
Esophageal Varices
17%
Nutrition
17%
Biochemistry, Genetics and Molecular Biology
Programmed Cell Death
69%
Cancer Cell
63%
Phosphotransferase
47%
Kinase
47%
N-Terminus
45%
Colon
31%
Retrospective Study
25%
Mitochondrial Membrane Potential
22%
P53
21%
Clinical Trial
20%
Prevalence
20%
Cytotoxicity
19%
Nocodazole
19%
Fucoidan
17%
Hsp90 Inhibitor
17%
Geldanamycin
17%
Radicicol
17%
Shotgun Sequencing
17%
Microbiome
17%
Tumor Antigen
17%
Metagenome
17%
Hemoglobin Blood Level
17%
Alanine Transaminase
17%
Hepatitis B Virus
17%
Radiofrequency
17%
Lipopolysaccharide
17%
Enzyme Activity
17%
Leptin
17%
Mitochondrion
17%
Nilotinib
17%
Adiponectin
17%
Nitric Oxide
17%
Skeletal Muscle
17%
Molecular Weight
15%
Progression Free Survival
12%
Overall Survival
12%
Rigidity
11%
Fusobacterium
10%
Protein Expression
10%
Heme Oxygenase
9%
Protein Phosphorylation
9%
Caspase 3
8%
Hemoglobins
8%
Survival Rate
7%
Proinflammatory Cytokine
7%
Anticancer
7%
Bifidobacterium longum
6%
Phylum
6%
Metaplasia
6%
Bacterium
6%
